Parametric Portfolio Associates’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $95K | Sell |
37,212
-27,878
| -43% | -$71.2K | ﹤0.01% | 3572 |
|
|
2021
Q4 | $191K | Buy |
+65,090
| New | +$191K | ﹤0.01% | 3435 |
|
|
2021
Q3 | – | Sell |
-214,286
| Closed | -$872K | – | 3666 |
|
|
2021
Q2 | $872K | Buy |
214,286
+20,281
| +10% | +$82.5K | ﹤0.01% | 2827 |
|
|
2021
Q1 | $875K | Buy |
194,005
+16,174
| +9% | +$72.9K | ﹤0.01% | 3224 |
|
|
2020
Q4 | $875K | Sell |
177,831
-36,032
| -17% | -$177K | ﹤0.01% | 3116 |
|
|
2020
Q3 | $1.27M | Sell |
213,863
-14,609
| -6% | -$86.6K | ﹤0.01% | 2772 |
|
|
2020
Q2 | $608K | Buy |
228,472
+154,598
| +209% | +$411K | ﹤0.01% | 3175 |
|
|
2020
Q1 | $144K | Sell |
73,874
-20,094
| -21% | -$39.2K | ﹤0.01% | 3640 |
|
|
2019
Q4 | $662K | Buy |
93,968
+28,849
| +44% | +$203K | ﹤0.01% | 3260 |
|
|
2019
Q3 | $640K | Buy |
65,119
+10,346
| +19% | +$102K | ﹤0.01% | 3247 |
|
|
2019
Q2 | $627K | Buy |
54,773
+1,434
| +3% | +$16.4K | ﹤0.01% | 3272 |
|
|
2019
Q1 | $536K | Buy |
53,339
+24,577
| +85% | +$247K | ﹤0.01% | 3302 |
|
|
2018
Q4 | $489K | Sell |
28,762
-1,161
| -4% | -$19.7K | ﹤0.01% | 3321 |
|
|
2018
Q3 | $526K | Buy |
29,923
+8,223
| +38% | +$145K | ﹤0.01% | 3391 |
|
|
2018
Q2 | $412K | Buy |
+21,700
| New | +$412K | ﹤0.01% | 3419 |
|